Novel Strategies in Antibody-Drug Conjugate (ADC) Development
mybcs
Antibody-drug conjugates (ADCs) are at the forefront of targeted cancer therapy, and next-generation ADCs are redefining the landscape by overcoming the limitations of earlier designs. These advancements span all three core […]